Prozinc Human Insulin

24 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2500.0%

Death Rate

Active Ingredients

Prozinc Human Insulin

Administration Routes

SubcutaneousUnknownOral

Species Affected

Cat 17

Dog 7

Most Affected Breeds

Domestic Shorthair 9

Domestic Longhair 4

Cat (unknown) 2

Pit Bull 1

Pug 1

Pinscher - Miniature 1

Schnauzer - Miniature 1

Maine Coon 1

Lhasa Apso 1

Terrier - Yorkshire 1

Most Reported Reactions

Lack of efficacy - NOS 15

Death by euthanasia 4

Lethargy (see also Central nervous system depression in Neurological) 3

INEFFECTIVE, GLYCEMIC CONTROL 3

Vomiting 3

Death 2

Seizure NOS 2

Hypoglycaemia 2

Diarrhoea 2

Elevated blood urea nitrogen (BUN) 2

Elevated symmetrical dimethylarginine (SDMA) 2

Anorexia 1

Outcome Breakdown

Outcome Unknown

9 (37.5%)

Ongoing

7 (29.2%)

Euthanized

4 (16.7%)

Recovered/Normal

2 (8.3%)

Died

2 (8.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.